4//SEC Filing
FELLOWS DAVID A 4
Accession 0001562180-25-000854
CIK 0001831363other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:30 PM ET
Size
5.9 KB
Accession
0001562180-25-000854
Insider Transaction Report
Form 4
FELLOWS DAVID A
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-01+18,650→ 18,650 totalExercise: $4.46Exp: 2035-01-31→ Common Stock (18,650 underlying)
Footnotes (2)
- [F1]This option was issued pursuant to the Issuer's Non-Employee Director Compensation Policy, under which the Reporting Person elected to receive this option in lieu of the Reporting Person's cash retainer fee of $70,000 for 2025.
- [F2]The option will vest as to 1/12th of the total shares subject thereto on each monthly anniversary measured from January 1, 2025, such that 100% of the shares subject to the option will be fully vested on January 1, 2026.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001041126
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:30 PM ET
- Size
- 5.9 KB